2009
DOI: 10.1038/ng.366
|View full text |Cite
|
Sign up to set email alerts
|

A common allele in RPGRIP1L is a modifier of retinal degeneration in ciliopathies

Abstract: Despite rapid advances in disease gene identification, the predictive power of the genotype remains limited, in part due to poorly understood effects of second-site modifiers. Here we demonstrate that a polymorphic coding variant of RPGRIP1L (retinitis pigmentosa GTPase regulator-interacting protein-1 like), a ciliary gene mutated in Meckel-Gruber (MKS) and Joubert (JBTS) syndromes, is associated with the development of retinal degeneration in patients with ciliopathies caused by mutations in other genes. As p… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

11
237
1

Year Published

2010
2010
2018
2018

Publication Types

Select...
4
3

Relationship

2
5

Authors

Journals

citations
Cited by 250 publications
(249 citation statements)
references
References 30 publications
11
237
1
Order By: Relevance
“…Although we cannot exclude the possibility that a second pathogenic mutation resides within intronic or regulatory regions of the gene, it is also plausible that the identified change could act as a genetic modifier of the clinical phenotype in an oligogenic context, and that digenic mutations may reside in another gene. This intriguing mechanism has been already postulated for several ciliopathies including Bardet-Biedl syndrome, NPH and even JSRD, [22][23][24][25] and could also help explain the intra-familial variability observed in some INPP5E-mutated families. To this end, the systematic genetic screening of multiple ciliopathy genes based on innovative technologies such as next-generation-sequencing is expected to give a main contribution to clarify the molecular basis underlying the clinical complexity of JSRD and other ciliopathies.…”
Section: Discussionmentioning
confidence: 59%
“…Although we cannot exclude the possibility that a second pathogenic mutation resides within intronic or regulatory regions of the gene, it is also plausible that the identified change could act as a genetic modifier of the clinical phenotype in an oligogenic context, and that digenic mutations may reside in another gene. This intriguing mechanism has been already postulated for several ciliopathies including Bardet-Biedl syndrome, NPH and even JSRD, [22][23][24][25] and could also help explain the intra-familial variability observed in some INPP5E-mutated families. To this end, the systematic genetic screening of multiple ciliopathy genes based on innovative technologies such as next-generation-sequencing is expected to give a main contribution to clarify the molecular basis underlying the clinical complexity of JSRD and other ciliopathies.…”
Section: Discussionmentioning
confidence: 59%
“…These phenotypes are consistent with abnormal planar cell polarity (PCP) signaling (21,22,24,25), which likely underlies several clinical phenotypes in patients who have BBS, including hearing defects (20), neural tube closure abnormalities (26), renal cyst formation (27), and possibly obesity and cognitive impairment (28). The fact that these observations are likely relevant to the etiopathology of BBS (20,21,(23)(24)(25), and true for all seven bbs orthologues tested (bbs1, bbs4, bbs6, bbs10, bbs12, mks1, and cep290) as well for as the three BBS modifiers mgc1203, mks3, and rpgrip1l, suggested that they might represent useful assays for all BBS genes. We therefore designed translation-blocking morpholinos (MOs) against bbs1-12 ( and SI Appendix, Table S1) and injected each into WT embryos at varying concentrations to establish a survival curve (SI Appendix, Table S3) from which to derive the optimal working MO concentration (minimal cytotoxicity, maximal phenotype).…”
Section: Resultsmentioning
confidence: 99%
“…Given that most of these variants can be found in homozygosity in control individuals suggests that they are insufficient to cause disease. However, we wondered whether they might interact with strong mutations to potentiate BBS, as shown recently for one of them, the A229T allele in RPGRIP1L (23).…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations